Model Number 5450-35-500 |
Device Problems
Loss of or Failure to Bond (1068); Loss of Osseointegration (2408)
|
Patient Problems
Adhesion(s) (1695); Muscular Rigidity (1968); Pain (1994); Swelling (2091); Limited Mobility Of The Implanted Joint (2671); No Code Available (3191); Joint Laxity (4526); Swelling/ Edema (4577)
|
Event Date 02/27/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).Initial reporter occupation: lawyer.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Event Description
|
The patient underwent a right knee revision due to pain, stiffness, swelling, decreased joint motion, instability, and tibial tray loosening at the bone to cement interface.The surgeon noted removing fibrous adhesions around the patella.Competitor products were implanted during the primary operation with depuy cement.During the revision, depuy attune revision products were implanted with competitor cement.Doi: (b)(6) 2016.Dor: (b)(6) 2018, right knee.
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provision depuy synthesof 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint # (b)(4).No device associated with this report was received for examination.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.Device history lot : device history review completed 12 dec 18.1 unrelated non-conformance on this lot number.Final micro and sterility tests passed.Device history batch : null.Device history review : null.If information is obtained that was not available for the initial medwatch, a follow-up medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: added: h6 (clinical and impact codes).Dmf# - (b)(4).Trade name ¿ gentamicin sulphate.Active ingredient(s) ¿ gentamicin sulphate.Dosage form - powder.Strength ¿ 1.0g active in our cements.The concomitant products were identified to be competitor products used in conjunction with the previously reported adverse event.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Corrected: d2b, d3, d10, g1, g4, h6 (medical device problem code).
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.Depuy synthes considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.Device history lot: device history review completed 12 dec 18.1 unrelated non-conformance on this lot number.Final micro and sterility tests passed.
|
|
Search Alerts/Recalls
|
|